Posters
- Nikos Zafiropoulos, et al.
Uncertainties and coping strategies in the regulatory review of orphan medicinal products
CEN-ISBS, Vienna, Austria, August 2017 - Susanne Urach.
Hypothesis tests for Goal Attainment Scaling
YSA, Vienna, Austria, June 2017 - Susanne Urach.
Improved testing of multiple endpoints in group sequential trials
YSA, Vienna, Austria, June 2016 - Rieke van der Graaf.
The Asterix benchmarks for ethically sound research in rare diseases
ECDR, Edinburgh, UK, May 2016 - Hanneke van der Lee.
The Asterix consortium: towards better evidence for new treatments for orphan diseases
ECDR, Edinburgh, UK, May 2016 - Charlotte Gaasterland.
A patients'view on rare disease research
ECDR, Edinburgh, UK, May 2016 - Charlotte Gaasterland.
Goal Attainment Scaling as an Outcome Measure in Orphan Drug Studies
Kindersymposium, Amsterdam, The Netherlands, Februari 2016 - Susanne Urach.
Group sequential designs for clinical trials with multiple treatment arms.
ISCB, Utrecht, the Netherlands, August 2015 - Susanne Urach, Martin Posch. Group sequential designs for clinical trials with multiple treatment arms. YSA Vienna, Austria, June 2015
- Charlotte Gaasterland.
POWER model: Patient participation in Outcome measure WEighing for Rare diseases.
COMET, Rome, Italy, November 2014 - Charlotte Gaasterland.
Systematic review of goal attainment scaling as an outcome measure in drug trials.
COMET, Rome, Italy, November 2014
